新冠疫情对德国黑色素瘤与非黑色素瘤皮肤癌住院治疗的影响——一项全国性分析
该研究对比德国疫情前一年(2019年3月18日至2020年3月17日)与疫情第一年(2020年3月18日至2021年3月17日)的全国住院数据,发现皮肤癌病例持续减少14%(n=19063),手术操作减少17%(n=22548),其中原位肿瘤减少24%、非黑色素瘤皮肤癌减少16%、恶性黑色素瘤减少7%。作者认为非黑色素瘤皮肤癌降幅大于黑色素瘤可能反映优先排序效应,并需肿瘤登记数据进一步研究治疗延迟的后果。
要点
- 疫情第一年皮肤癌住院病例较前一年持续减少14%(n=19063)。
- 原位肿瘤减少24%(n=1665),非黑色素瘤皮肤癌减少16%(n=15310),恶性黑色素瘤减少7%(n=2088)。
- 手术操作减少17%(n=22548),小手术减少24.6%,扩大皮肤手术含显微手术减少15.9%。
核心结论
- 自疫情开始以来德国皮肤癌患者的住院入院和手术操作持续减少。
- 非黑色素瘤皮肤癌病例降幅高于恶性黑色素瘤可能反映优先排序效应。
- 需要来自肿瘤登记处的进一步证据来研究治疗延迟的后果并识别皮肤癌诊疗中即将面临的挑战。
研究设计与样本
- 比较分析疫情前队列(2019年3月18日至2020年3月17日)与疫情队列(2020年3月18日至2021年3月17日)的德国全国住院数据集。
- 使用世界卫生组织国际疾病分类编码(ICD)和操作与程序编码(OPS)识别和分析病例。
主要发现
- 疫情第一年较前一年同期皮肤癌病例持续减少14%(n=19063)。
- 原位肿瘤减少24%(n=1665),非黑色素瘤皮肤癌减少16%(n=15310),恶性黑色素瘤减少7%(n=2088)。
- 亚组分析显示性别、年龄、医院举办类型和医院规模分布存在显著差异。
- 手术操作减少17%(n=22548),小手术减少24.6%,扩大皮肤手术含显微手术减少15.9%。
关键数值与推荐
- 皮肤癌病例总体减少14%(n=19063)。
- 原位肿瘤减少24%(n=1665)。
- 非黑色素瘤皮肤癌减少16%(n=15310)。
- 恶性黑色素瘤减少7%(n=2088)。
- 手术操作减少17%(n=22548),其中小手术减少24.6%,扩大皮肤手术含显微手术减少15.9%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要来自肿瘤登记处的进一步证据来研究治疗延迟的后果并识别皮肤癌诊疗中即将面临的挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: SARS-CoV-2 has massively changed the care situation in hospitals worldwide. Although tumour care should not be affected, initial reports from European countries were suggestive for a decrease in skin cancer during the first pandemic wave and only limited data are available thereafter. OBJECTIVES: The aim of this study was to investigate skin cancer cases and surgeries in a nationwide inpatient dataset in Germany. METHODS: Comparative analyses were performed in a prepandemic (18 March 2019 until 17 March 2020) and a pandemic cohort (18 March 2020 until 17 March 2021). Cases were identified and analysed using the WHO international classification of diseases codes (ICDs) and process key codes (OPSs). RESULTS: Comparing the first year of the pandemic with the same period 1 year before, a persistent decrease of 14% in skin cancer cases (n = 19 063) was observed. The largest decrease of 24% was seen in non-invasive in situ tumours (n = 1665), followed by non-melanoma skin cancer (NMSC) with a decrease of 16% (n = 15 310) and malignant melanoma (MM) with a reduction of 7% (n = 2088). Subgroup analysis showed significant differences in the distribution of sex, age, hospital carrier type and hospital volume. There was a decrease of 17% in surgical procedures (n = 22 548), which was more pronounced in minor surgical procedures with a decrease of 24.6% compared to extended skin surgery including micrographic surgery with a decrease of 15.9%. CONCLUSIONS: Hospital admissions and surgical procedures decreased persistently since the beginning of the pandemic in Germany for skin cancer patients. The higher decrease in NMSC cases compared to MM might reflect a prioritization effect. Further evidence from tumour registries is needed to investigate the consequences of the therapy delay and identify the upcoming challenges in skin cancer care.
引用
- Kleemann J, Meissner M, Özistanbullu D, et al. Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany - a nationwide analysis. J Eur Acad Dermatol Venereol. 2022. PMID: 35570468. doi:10.1111/jdv.18217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。